Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Genome Association Study (GWAS) to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of Irritable Bowel Syndrome (IBS) Symptoms

NCT06912828 is registered in ClinicalTrials.gov with Attikon Hospital as lead sponsor.

NCT NCT06912828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06912828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Genome Association Study (GWAS) to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of Irritable Bowel Syndrome (IBS) Symptoms
Lead sponsor
Attikon Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2024
Completion date
February 15, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fodmap diet, genome-wide association study, irritable bowel syndrome (ibs), mediterranean diet, single nucleotide polymorphisms